Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons
- PMID: 19111932
- DOI: 10.1016/j.lungcan.2008.11.009
Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons
Abstract
We aimed to evaluate the CT, PET, and pathologic findings of solitary pulmonary nodular mucinous and nonmucinous bronchioloalveolar carcinomas (BACs). From August 2003 to March 2008, we saw 24 patients with solitary pulmonary nodular mucinous (n=6) or nonmucinous (n=18) BACs that were resected. CT and PET findings of the lesions were assessed in terms of size, solidity, morphologic characteristics, attenuation and maximum standardized uptake value (mSUV). All nonmucinous BACs appeared as a pure ground-glass opacity (GGO) nodule, whereas mucinous BACs appeared as solid (n=4) or part-solid (n=2) nodules. CT attenuation values were significantly higher for mucinous BACs (-21.0 HU+/-4.9) than for nonmucinous BACs (-491.8 HU+/-172.5) (P<.001). Mean mSUVs were 2.3+/-1.9 for mucinous BACs and 0.5+/-0.8 for nonmucinous BACs (P=.007), but mSUVs were not statistically different after size adjustment (r=0.371, P=.081). Mucinous BACs appear as solid or part-solid nodules at CT, whereas nonmucinous BACs present as pure GGO nodules. Both subtypes of tumors show scant FDG uptake at PET.
Similar articles
-
Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.Am J Clin Pathol. 2001 Sep;116(3):319-25. doi: 10.1309/550P-QLJX-D84W-F6DN. Am J Clin Pathol. 2001. PMID: 11554157
-
Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.Lung Cancer. 2008 Aug;61(2):186-94. doi: 10.1016/j.lungcan.2007.12.021. Epub 2008 Feb 15. Lung Cancer. 2008. PMID: 18280613
-
Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings.Lung Cancer. 2009 Dec;66(3):379-85. doi: 10.1016/j.lungcan.2009.02.011. Epub 2009 Mar 18. Lung Cancer. 2009. PMID: 19299033
-
Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.J Thorac Imaging. 2011 May;26(2):106-18. doi: 10.1097/RTI.0b013e3181fbaa64. J Thorac Imaging. 2011. PMID: 21508733 Review.
-
Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.Radiographics. 1997 Nov-Dec;17(6):1345-57. doi: 10.1148/radiographics.17.6.9397450. Radiographics. 1997. PMID: 9397450 Review.
Cited by
-
Clinical importance of [18F]fluorodeoxyglucose positron emission tomography/computed tomography in the management of patients with bronchoalveolar carcinoma: Role in the detection of recurrence.Oncol Lett. 2013 May;5(5):1687-1693. doi: 10.3892/ol.2013.1257. Epub 2013 Mar 14. Oncol Lett. 2013. PMID: 23761835 Free PMC article.
-
Multidimensional biological characteristics of ground glass nodules.Front Oncol. 2024 May 22;14:1380527. doi: 10.3389/fonc.2024.1380527. eCollection 2024. Front Oncol. 2024. PMID: 38841161 Free PMC article. Review.
-
Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.Biomed Res Int. 2015;2015:243681. doi: 10.1155/2015/243681. Epub 2015 Mar 24. Biomed Res Int. 2015. PMID: 25879020 Free PMC article.
-
Invasive Mucinous Adenocarcinoma with Acute Respiratory Distress Syndrome Diagnosed by Autopsy Findings.Intern Med. 2023 Jul 15;62(14):2107-2111. doi: 10.2169/internalmedicine.0926-22. Epub 2022 Nov 23. Intern Med. 2023. PMID: 36418103 Free PMC article.
-
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings.Onco Targets Ther. 2016 Dec 28;10:153-163. doi: 10.2147/OTT.S121059. eCollection 2017. Onco Targets Ther. 2016. PMID: 28096683 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical